Anna Zhao advises clients on a broad range of regulatory and compliance matters with primary focus in the life sciences industry. Her practice includes providing advice on U.S. and China regulatory matters involving food, drugs, devices, cosmetics, and other regulated products. She regularly advises clients on product development and approval, informed consent, regulatory exclusivities, labeling, and promotion issues, as well as related legislative advocacy matters.
In addition to her advisory practice, Ms. Zhao also represents clients in complex government enforcement actions and internal investigations on a variety of issues, including clinical trial misconduct, data reporting and integrity, and promotion issues.
As a native Chinese and fluent English speaker, Ms. Zhao is particularly well-equipped to support the need of Chinese companies and western companies clients with operations in China on cross-border issues. She has broad experience helping clients navigate China’s trade and investment laws and policies and develop best approaches of entering the Chinese market.
Ms. Zhao is qualified to practice Chinese law, admitted to practice in the State of New York, and licensed in the District of Columbia as a Special Legal Consultant.